title: Strategy vaccination against Hepatitis B in China.
abstract: Hepatitis B (HB) is a serious public health problem in China. Up to now, the hepatitis B virus (HBV) vaccination was the most cost-effective way to prevent HBV infection. Since 1992, when the Chinese government prioritized implementing the HBV vaccinations for newborns, China began to see a larger reduction in HBV infections. For children under 5 years, the prevalence of hepatitis B surface antigen (HBsAg) has decreased to 1.0%. However, many additional challenges for the prevention and control of HBV infection in China remain. There is a lack of knowledge of the significant impact of the HBV vaccination for the general public with 93 million HBV carriers and chronic HBV patients as infection sources. Therefore, the HBV vaccine application should focus on the optimization of immunization strategies according to HBV prevalence characteristics, improve the public's knowledge of HBV vaccinations, and help to ensure the protective effects of the HBV vaccine.
authors.affiliation: a National Institutes for Food and Drug Control No.2 ; Tiantan Xili ; Beijing , China.
authors.forename: Xueyan
authors.initials: X
authors.lastname: Liao
authors.forename: Zhenglun
authors.initials: Z
authors.lastname: Liang
mesh_terms: D002681:China / Q000453:epidemiology; D006509:Hepatitis B / Q000453:epidemiology* / Q000517:prevention & control*; D017325:Hepatitis B Vaccines / Q000008:administration & dosage*; D006801:Humans; D015995:Prevalence; D014611:Vaccination / Q000379:methods*
chemical_list: D017325:Hepatitis B Vaccines
keywords: Hepatitis B vaccine; Hepatitis B virus (HBV); immunization strategies